phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma

NIH RePORTER · NIH · P50 · $342,106 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10468352
Project number
5P50CA221747-03
Recipient
NORTHWESTERN UNIVERSITY
Principal Investigator
MACIEJ S LESNIAK
Activity code
P50
Funding institute
NIH
Fiscal year
2020
Award amount
$342,106
Award type
5
Project period
2020-08-01 → 2023-07-31